User profiles for Yu Hu
Yu HuMicrosoft Verified email at microsoft.com Cited by 531 |
[HTML][HTML] Clinical characteristics of 2019 novel coronavirus infection in China
W Guan, Z Ni, Y Hu, W Liang, C Ou, J He, L Liu… - MedRxiv, 2020 - medrxiv.org
Background Since December 2019, acute respiratory disease (ARD) due to 2019 novel
coronavirus (2019-nCoV) emerged in Wuhan city and rapidly spread throughout China. We …
coronavirus (2019-nCoV) emerged in Wuhan city and rapidly spread throughout China. We …
[HTML][HTML] Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research
…, M Madjid, Y Guo, LV Tang, Y Hu… - Thrombosis and …, 2020 - thieme-connect.com
Coronavirus disease 2019 (COVID-19), currently a worldwide pandemic, is a viral illness
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The suspected …
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The suspected …
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the severe acute
respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients to thrombotic …
respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients to thrombotic …
The molecular characteristics dominating the solubility of gases in ionic liquids
YF Hu, ZC Liu, CM Xu, XM Zhang - Chemical Society Reviews, 2011 - pubs.rsc.org
This critical review provides a critical discussion of the current state of knowledge of the key
factors influencing the solubility of gases in ionic liquids (ILs), including sample purity, …
factors influencing the solubility of gases in ionic liquids (ILs), including sample purity, …
[HTML][HTML] Structural and functional basis of SARS-CoV-2 entry by using human ACE2
…, L Wu, S Niu, C Song, Z Zhang, G Lu, C Qiao, Y Hu… - Cell, 2020 - cell.com
The recent emergence of a novel coronavirus (SARS-CoV-2) in China has caused significant
public health concerns. Recently, ACE2 was reported as an entry receptor for SARS-CoV-2…
public health concerns. Recently, ACE2 was reported as an entry receptor for SARS-CoV-2…
Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study
…, P Yin, Y Wang, L Tang, J Deng, H Mei, Y Hu - The Lancet …, 2020 - thelancet.com
Background COVID-19 is an ongoing global pandemic. Changes in haematological
characteristics in patients with COVID-19 are emerging as important features of the disease. We …
characteristics in patients with COVID-19 are emerging as important features of the disease. We …
Inflammation and the pathogenesis of atrial fibrillation
YF Hu, YJ Chen, YJ Lin, SA Chen - Nature Reviews Cardiology, 2015 - nature.com
Atrial fibrillation (AF) is the most common cardiac arrhythmia. However, the development of
preventative therapies for AF has been disappointing. The infiltration of immune cells and …
preventative therapies for AF has been disappointing. The infiltration of immune cells and …
Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China
L Mao, H Jin, M Wang, Y Hu, S Chen, Q He… - JAMA …, 2020 - jamanetwork.com
Importance The outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China, is serious
and has the potential to become an epidemic worldwide. Several studies have described …
and has the potential to become an epidemic worldwide. Several studies have described …
Clinical characteristics of coronavirus disease 2019 in China
W Guan, Z Ni, Y Hu, W Liang, C Ou, J He… - New England journal …, 2020 - Mass Medical Soc
Background Since December 2019, when coronavirus disease 2019 (Covid-19) emerged in
Wuhan city and rapidly spread throughout China, data have been needed on the clinical …
Wuhan city and rapidly spread throughout China, data have been needed on the clinical …
Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial
…, Q Wei, H Mei, C Hu, C Tao, R Yang, J Wang, Y Yu… - Jama, 2020 - jamanetwork.com
Importance Convalescent plasma is a potential therapeutic option for patients with coronavirus
disease 2019 (COVID-19), but further data from randomized clinical trials are needed. …
disease 2019 (COVID-19), but further data from randomized clinical trials are needed. …